vs
太平洋生物科学（ASMB）与CHICAGO RIVET & MACHINE CO（CVR）财务数据对比。点击上方公司名可切换其他公司
太平洋生物科学的季度营收约是CHICAGO RIVET & MACHINE CO的1.8倍（$10.8M vs $6.0M），CHICAGO RIVET & MACHINE CO净利率更高（-19.3% vs -85.2%，领先65.9%），太平洋生物科学同比增速更快（57.6% vs 45.9%），CHICAGO RIVET & MACHINE CO自由现金流更多（$24.3K vs $-15.2M）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
芝加哥气动（简称CP）是一家工业制造企业，主营动力工具、空气压缩机、发电机、照明灯塔及液压设备，产品通过全球分销网络销往150多个国家，业务覆盖工业生产工具、汽车维修、采矿维保检修、工程建设、基础设施设备等多个领域。
ASMB vs CVR — 直观对比
营收规模更大
ASMB
是对方的1.8倍
$6.0M
营收增速更快
ASMB
高出11.8%
45.9%
净利率更高
CVR
高出65.9%
-85.2%
自由现金流更多
CVR
多$15.2M
$-15.2M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $6.0M |
| 净利润 | $-9.2M | $-1.2M |
| 毛利率 | — | 2.7% |
| 营业利润率 | -100.9% | -15.3% |
| 净利率 | -85.2% | -19.3% |
| 营收同比 | 57.6% | 45.9% |
| 净利润同比 | 4.3% | 68.0% |
| 每股收益（稀释后） | $-0.72 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBCVR
| Q4 25 | — | $6.0M | ||
| Q3 25 | $10.8M | $7.4M | ||
| Q2 25 | $9.6M | $7.3M | ||
| Q1 25 | $9.4M | $7.2M | ||
| Q4 24 | $7.4M | $4.1M | ||
| Q3 24 | $6.8M | $7.0M | ||
| Q2 24 | $8.5M | $8.1M | ||
| Q1 24 | $5.8M | $7.9M |
净利润ASMBCVR
| Q4 25 | — | $-1.2M | ||
| Q3 25 | $-9.2M | $67.6K | ||
| Q2 25 | $-10.2M | $-395.0K | ||
| Q1 25 | $-8.8M | $401.0K | ||
| Q4 24 | — | $-3.6M | ||
| Q3 24 | $-9.6M | $-1.4M | ||
| Q2 24 | $-11.2M | $142.1K | ||
| Q1 24 | $-9.1M | $-698.0K |
毛利率ASMBCVR
| Q4 25 | — | 2.7% | ||
| Q3 25 | — | 18.1% | ||
| Q2 25 | — | 13.4% | ||
| Q1 25 | — | 22.9% | ||
| Q4 24 | — | -43.7% | ||
| Q3 24 | — | 10.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 9.5% |
营业利润率ASMBCVR
| Q4 25 | — | -15.3% | ||
| Q3 25 | -100.9% | 0.9% | ||
| Q2 25 | -115.2% | -5.7% | ||
| Q1 25 | -105.5% | 1.0% | ||
| Q4 24 | — | -86.4% | ||
| Q3 24 | -160.1% | -11.8% | ||
| Q2 24 | -143.0% | 1.3% | ||
| Q1 24 | -185.5% | -11.5% |
净利率ASMBCVR
| Q4 25 | — | -19.3% | ||
| Q3 25 | -85.2% | 0.9% | ||
| Q2 25 | -105.9% | -5.4% | ||
| Q1 25 | -93.6% | 5.5% | ||
| Q4 24 | — | -88.0% | ||
| Q3 24 | -140.4% | -20.8% | ||
| Q2 24 | -130.7% | 1.8% | ||
| Q1 24 | -156.9% | -8.9% |
每股收益（稀释后）ASMBCVR
| Q4 25 | — | — | ||
| Q3 25 | $-0.72 | — | ||
| Q2 25 | $-1.33 | — | ||
| Q1 25 | $-1.17 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-1.51 | — | ||
| Q2 24 | $-1.98 | — | ||
| Q1 24 | $-1.66 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | $1.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $182.7M | $18.8M |
| 总资产 | $240.0M | $23.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASMBCVR
| Q4 25 | — | $1.7M | ||
| Q3 25 | $22.5M | $1.7M | ||
| Q2 25 | $24.0M | $1.2M | ||
| Q1 25 | $23.4M | $765.6K | ||
| Q4 24 | $38.3M | $2.2M | ||
| Q3 24 | $28.5M | $2.2M | ||
| Q2 24 | $19.2M | $2.6M | ||
| Q1 24 | $18.7M | $2.7M |
总债务ASMBCVR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ASMBCVR
| Q4 25 | — | $18.8M | ||
| Q3 25 | $182.7M | $20.0M | ||
| Q2 25 | $18.1M | $20.0M | ||
| Q1 25 | $27.1M | $20.4M | ||
| Q4 24 | $33.4M | $20.0M | ||
| Q3 24 | $26.0M | $23.7M | ||
| Q2 24 | $34.7M | $25.2M | ||
| Q1 24 | $32.6M | $25.2M |
总资产ASMBCVR
| Q4 25 | — | $23.3M | ||
| Q3 25 | $240.0M | $24.0M | ||
| Q2 25 | $80.8M | $23.6M | ||
| Q1 25 | $99.0M | $24.1M | ||
| Q4 24 | $119.2M | $23.4M | ||
| Q3 24 | $100.3M | $26.4M | ||
| Q2 24 | $115.3M | $27.3M | ||
| Q1 24 | $119.9M | $27.8M |
负债/权益比ASMBCVR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $116.4K |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | $24.3K |
| 自由现金流率自由现金流/营收 | -140.7% | 0.4% |
| 资本支出强度资本支出/营收 | 0.4% | 1.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-1.6M |
8季度趋势，按日历期对齐
经营现金流ASMBCVR
| Q4 25 | — | $116.4K | ||
| Q3 25 | $-15.1M | $638.0K | ||
| Q2 25 | $-16.8M | $28.2K | ||
| Q1 25 | $-23.4M | $-2.0M | ||
| Q4 24 | $-51.1M | $-60.1K | ||
| Q3 24 | $-15.2M | $-58.2K | ||
| Q2 24 | $-17.1M | $363.5K | ||
| Q1 24 | $-18.4M | $-398.8K |
自由现金流ASMBCVR
| Q4 25 | — | $24.3K | ||
| Q3 25 | $-15.2M | $492.1K | ||
| Q2 25 | — | $-22.8K | ||
| Q1 25 | — | $-2.1M | ||
| Q4 24 | $-51.1M | $-118.1K | ||
| Q3 24 | — | $-368.9K | ||
| Q2 24 | $-17.1M | $58.0K | ||
| Q1 24 | $-18.4M | $-491.8K |
自由现金流率ASMBCVR
| Q4 25 | — | 0.4% | ||
| Q3 25 | -140.7% | 6.7% | ||
| Q2 25 | — | -0.3% | ||
| Q1 25 | — | -28.3% | ||
| Q4 24 | -695.2% | -2.9% | ||
| Q3 24 | — | -5.3% | ||
| Q2 24 | -200.6% | 0.7% | ||
| Q1 24 | -317.7% | -6.3% |
资本支出强度ASMBCVR
| Q4 25 | — | 1.5% | ||
| Q3 25 | 0.4% | 2.0% | ||
| Q2 25 | 0.0% | 0.7% | ||
| Q1 25 | 0.0% | 0.6% | ||
| Q4 24 | 0.4% | 1.4% | ||
| Q3 24 | 0.0% | 4.5% | ||
| Q2 24 | 0.2% | 3.8% | ||
| Q1 24 | 0.2% | 1.2% |
现金转化率ASMBCVR
| Q4 25 | — | — | ||
| Q3 25 | — | 9.44× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -5.01× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 2.56× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASMB
暂无分部数据
CVR
| Fastener | $5.1M | 85% |
| Other | $890.7K | 15% |
